Risedronic acid (INN) or risedronate sodium (USAN) is a bisphosphonate used to strengthen bone treat or prevent osteoporosis and treat Paget’s disease of bone. It is produced and marketed by Warner Chilcott Sanofi-Aventis and in Japan by Takeda under the trade names Actonel Atelvia and Benet. It is also available in a preparation that includes a calcium carbonate supplement as Actonel with Calcium.
This page contains content from the copyrighted Wikipedia article "Risedronic acid"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
